To reduce the price of prescription drugs in the United States by more than 50 percent by adopting Most Favored Nation drug pricing so that the American people pay no more for prescription drugs than Europeans or Canadians.

This legislation aims to drastically lower prescription drug costs by mandating that prices in the United States do not exceed the lowest prices charged in other developed nations, such as those in Europe or Canada. By adopting a "Most Favored Nation" pricing model, the bill forces pharmaceutical companies to align American prices with these lower international benchmarks. For Arlington residents, this move could lead to significant relief at the pharmacy counter, potentially cutting out-of-pocket expenses by more than half for many common medications. While the policy targets national pharmaceutical pricing structures, the ultimate effect for local families would be a substantial reduction in the financial burden associated with managing chronic conditions and accessing essential healthcare, making necessary treatments far more affordable for the average household.